TIGIT as an Emerging Immune Checkpoint

Clinical and Experimental Immunology - United Kingdom
doi 10.1111/cei.13407
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

P3.12-13 Expression of the Immune Checkpoint Axis-PVR/Tigit in Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies

Cancer Cell
Cancer ResearchOncologyCell Biology
2018English

TIGIT Limits Immune Pathology During Viral Infections

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2020English

Beyond Chemotherapy: Emerging Biomarkers and Therapies as Small Cell Lung Cancer Enters the Immune Checkpoint Era

Cancer
Cancer ResearchOncology
2019English

Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors

Advances in Therapy
MedicinePharmacology
2019English

Immune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging Issue

Oncologist
Cancer ResearchMedicineOncology
2018English

Mechanisms of TIGIT-driven Immune Suppression in Cancer

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

TLR2 – An Innate Immune Checkpoint in Multiple Sclerosis

Oncotarget
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy